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DObjectives: We examined the effect of avoiding cardiopulmonary bypass on the early outcome variables after
fenestrated extracardiac total cavopulmonary connection.
Methods: Between May 2001 and January 2009, 102 patients with univentricular heart physiology underwent
fenestrated extracardiac total cavopulmonary connection. Patients were divided into one of 2 groups: the cardio-
pulmonary bypass (n¼ 48) group and the no cardiopulmonary bypass (n ¼ 54) group. In both groups there were
patients with primary and staged fenestrated extracardiac total cavopulmonary connection. Duration of mechan-
ical ventilation, pleural effusion, hemodynamic status, incidence of arrhythmia, and mortality were compared
between the 2 groups.
Results: Both groups were matched, except for more cases of tricuspid atresia in the no cardiopulmonary bypass
group (P¼ .014) compared with other diagnostic morphologies and higher preoperative hemoglobin levels in the
no cardiopulmonary bypass group (P ¼ .01). Avoiding cardiopulmonary bypass did not reveal any significant
effect on postoperative outcomes. A cardiopulmonary bypass time of more than 120 minutes caused not only
a meaningful increase in the mean of mechanical ventilation duration (35  9.6 vs 13  2.1 hours, P ¼ .026)
but also increased the incidence of mechanical ventilation for more than 12 hours (P ¼ .04). Bypass time of
more than 120 minutes did not have influence on any other postoperative variables.
Conclusion: Avoiding cardiopulmonary bypass in fenestrated extracardiac total cavopulmonary connection had
no direct effect on the early outcome variables. (J Thorac Cardiovasc Surg 2010;139:1183-8)Earn CME credits at
http://cme.ctsnetjournals.org
The early and midterm outcomes of surgical management in
patients with a single ventricle have been influenced by
many factors, especially by the modifications made to im-
prove the flow dynamics in the Fontan operation since its
first successful performance in 1971.1 The dramatic im-
provements in morbidity and mortality have been credited
to both better selection and technical modifications that
include lateral tunnels, staging, fenestration, extracardiac
conduits, and avoidance of cardiopulmonary bypass
(CPB). However, various studies have yielded different
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The Journal of Thoracic and Carselection criteria, the modifications implemented, and the
definition of outcome variables.2–5 There are multiple stud-
ies that showed the feasibility of performing fenestrated
extracardiac total cavopulmonary connection (FECTCPC)
without the use of CPB.6–11 However, the effect of avoiding
CPB on early outcome has not been thoroughly examined.
Furthermore, the majority of prior studies in which
FECTCPC was performed without the use of CPB were
staged, and the combined effects of primary versus staging
with or without CPB have not been studied either. This
report tries to address these issues in a group of matched
patients after primary and staged FECTCPC.
MATERIALS AND METHODS
To assess the effect of CPB on the early outcome of patients palliated
with extracardiac total cavopulmonary connection, 102 single-ventricle pa-
tients who were operated on by a single surgeon with this type of interven-
tion from May 2001 to January 2009 were enrolled in the study.
Both demographic and clinical data during the pre-, intra-, and post-Fon-
tan periods were gathered from a preformatted form and patients’ medical
records. The longer-term follow-up information was collected from
follow-up records completed by cardiologists and the cardiac surgeon.
Demographic characteristics (age and weight), morphologic features
(tricuspid atresia [TA] and non-TA), oxygen saturation in room air, pulmo-
nary vascular resistance (PVR), and pulmonary artery (PA) pressure were
compared between the CPB and no-CPB groups. Collected intraoperative
information included superior vena cava (SVC), inferior vena cava (IVC),
and PA pressures in addition to post-Fontan transpulmonary pressure gra-
dient (TPG) changes. TPG equals the mean PA pressure minus the meandiovascular Surgery c Volume 139, Number 5 1183
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
FECTCPC ¼ fenestrated extracardiac
total cavopulmonary connection
ICU ¼ intensive care unit
IVC ¼ inferior vena cava
PA ¼ pulmonary artery
PVR ¼ pulmonary vascular resistance
SVC ¼ superior vena cava
TA ¼ tricuspid atresia
TPG ¼ transpulmonary pressure gradient
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Datrial pressure. Intraoperative TPG change was defined as the difference
between the TPG values before and after extracardiac total cavopulmonary
connection.
The outcome variables during the immediate postoperative period were
duration of mechanical ventilation, duration of chest tube drainage in hours,
persistent pleural effusion, arrhythmia, hemodynamic instability in the in-
tensive care unit (ICU), and early mortality. We did not use the length of
ICU stay as an outcome variable because it would be affected by many fac-
tors, such as the limited number of ward beds, which can delay patient trans-
fer from the ICU to the ward. Mechanical ventilation duration is the time
from the patient’s arrival to the ICU until extubation. Persistent pleural ef-
fusion was defined as either when chest tubes were required to be in place
for more than 7 days or the patient required repeated drainage after removal
of the chest tubes. Arrhythmia was considered as any deviation from normal
sinus rhythm, even transient deviation. Hemodynamic instability was de-
fined as when the ejection fraction was less than 50%, as determined by
means of transthoracic echocardiographic analysis; inability to maintain he-
modynamic stability despite conventional doses of inotropes (milrinone,
0.75 mg $ kg1 $ min1; epinephrine, 0.05–0.1 mg $ kg1 $ min1); oliguria;
or delayed rewarming for more than 3 to 5 hours. Mortality was considered
early if death occurred within 30 days after the operation and late if death
occurred more than 30 days after the operation. In-hospital mortality was
defined as death occurring during the same hospitalization as the surgical
procedure, regardless of when after the operation the death occurred. The
number of deaths and operations would be the numerator and the denomi-
nator, respectively.12
Patient Population
A total of 102 patients palliated with FECTCPC were enrolled nonran-
domly into the study. Reasons that CPB was used electively included an in-
tracardiac procedure (eg, enlargement of either an atrial or ventricular septal
defect) in 22 patients and absence of accessory pulmonary blood flow in 7
patients. Intraoperatively, we decided to use CPB in 17 patients because of
the blood pressure decrease or arrhythmia and in 2 patients for the correction
of cardiac lacerations resulting in massive bleeding.
We electively performed primary FECTCPC because of the older age of
our patients, unless one of the following criteria for staging existed: post-PA
banding, extensive PA reconstruction, intraoperative mean PA pressure of
greater than 15 mm Hg, ventricular dysfunction, and azygous continuation
of the IVC. This study was approved by the ethics committee of our
institute. Informed consent was obtained for data extracting from patients’
medical files.
Statistical Analysis
Our study was a clinical trial without randomization. Both univariate
and multivariate analyses were used for data analysis. In univariate analysis1184 The Journal of Thoracic and Cardiovascular Surcontinuous variables were tested for normality by using the Kolmogorov–
Smirnov goodness-of-fit test. Normal data were compared among groups
by means of independent samples t tests. With nonnormal data, we used
the Mann–Whitney test to compare 2 groups or the Kruskal–Wallis test
to compare more than 2 groups. We showed the continuous results with
means and standard deviations. The Pearson c2 test and the Fisher’s exact
test were used to test the relationship between qualitative variables. Further-
more, the Mantel–Haenszel test was applied to adjust the effect of con-
founding variables. For data analysis, SPSS software (version 15; SPSS,
Inc, Chicago, Ill) was used.
Surgical Technique
In the no-CPB technique 2 central venous line monitoring catheters were
placed. One catheter was placed in either the right or left internal jugular
vein, and the other was placed in either the right or left groin. After full hep-
arinization, a temporary bypass, an SVC–atrial shunt, is constructed with 2
right-angled venous cannulas (SVC cannula of 14F–24F and atrial cannula
of 24F–32F) to crossclamp the single SVCs. In patients having bilateral
SVCs, the veins could be simply crossclamped one by one without placing
a temporary bypass. We chose the shortest possible cannula so as to mini-
mize resistance while keeping it out of the field. Drainage of the SVC
into the PA through temporary bypass tubing was helpful when no previous
aortopulmonary shunt was present or when the previous right modified Bla-
lock–Taussig shunt had to be replaced with the SVC–PA anastomosis. The
SVC was connected to the PA after side-biting, finalizing the bidirectional
cavopulmonary anastomosis. The azygous vein was ligated in the staged
procedure and left intact in the primary Fontan operation. The enlarged non-
cardiac end of the main PA was then anastomosed to the selected polytetra-
fluoroethylene tube conduit (14–22 mm). We optimized the conduit
dimensions in relation to the intraoperatively measured actual IVC
diameter, with the upper limit of the conduit/IVC ratio being approximately
1.2. For most children, the conduit was 18 to 20 mm in diameter. Direct IVC
cannulation at the most inferior site decompressed the IVC blood to the
atrium through the temporary shunt (straight cannula, 18F–28F). The
venoatrial junction was divided obliquely, leaving a short rim of atrial tissue
around the IVC. Here mobilization of pericardial reflection was very helpful
to achieve an adequate stump at both sides. The inferior end of the conduit
was anastomosed end-to-end to the noncardiac end of the IVC.
We selectively performed superior conduit anastomosis first to decrease
IVC hypertension in the no-CPB group.
In older patients with a weight of greater than 40 kg, temporarily bypass-
ing the IVC to the atrium with the available cannula could result in IVC hy-
pertension, postoperative jaundice, and increased serum amylase levels. The
superior polytetrafluoroethylene conduit–PA anastomosis was performed
first to minimize this risk. When the IVC drainage becomes inadequate
and the IVC pressure exceeds 20 mmHg, it is advised to side-bite the lateral
IVC–atrial junction for end-to-side conduit–IVC anastomosis before pro-
ceeding to crossclamp and transect this junction. When the only source of
blood flow to the lungs was a right aortopulmonary shunt, an IVC–PA path-
way was reconstructed first. In the case that the shunt was placed near the
hilum, it was possible to preserve the shunt temporally and implant the
SVC onto the PA.
CPB was performed with ascending aortic and bicaval cannulation
during moderate hypothermia (rectal temperature, 28C–30C). Cardiac ar-
rest with crystalloid cardioplegia was avoided unless a concomitant intracar-
diac operation was necessary. Cardioplegia was repeated at 20-minute
intervals.
Fenestration was created in all cases with direct 4- to 6-mm side-to-side
anastomosis of the extracardiac conduit to the atrium by using the punch
technique and suturing atrial wall tissue around the fenestration distant
from the fenestration’s edge to ease possible device closure. After decannu-
lation, protamine was administered only when hemostasis was not satisfac-
tory. Bilateral pleural chest tubes were placed in all patients. We removed
them once drainage was less than 2 mL $ kg1 $ d1 for each tube. It isgery c May 2010
Navabi et al Congenital Heart Diseasespeculated that this protocol minimizes the need for chest tube reinsertion
after removal.13 We considered early postoperative anticoagulation therapy
with warfarin to achieve a target international normalized ratio of 2 after dis-
charge from the hospital.C
H
DRESULTS
Preoperative and Perioperative Results
Of 102 enrolled patients, 54 (53%) had primary and 48
(47%) had staged FECTCPC operations. The patient popu-
lation was divided into those who did not receive CPB (n ¼
54 [53%]) and those who received CPB (n¼ 48 [47%]). No
differences were found in age; weight; PVR; SVC, IVC, and
PA pressures; and oxygen saturation between the no-CPB
and CPB groups preoperatively (Table 1). Previous and con-
comitant operations in both groups are shown in Table 2.
There was a significant difference in the distribution of
TA and non-TA between the 2 groups. There were 30
(55%) TA and 24 (45%) non-TA morphologies in the no-
CPB group versus 15 (31%) TA and 33 (69%) non-TAmor-
phologies in the CPB group (P ¼ .014). Also, a significant
difference was seen in the hemoglobin values between the
2 groups. In the no-CPB group the mean preoperative hemo-
globin value was higher due to the higher prevalence of
cyanotic patients (more patients without a previous bidirec-
tional Glenn procedure) in this group (Table 1). Periopera-
tive pressures did not show any difference between the 2
groups, neither in the SVC, IVC, and PA pressures nor in
the TPG changes.
Six (11%) patients in the no-CPB and 5 (10%) in the CPB
group had PA pressures of greater than 15 mm Hg. In addi-
tion, 3 (6%) patients with severe atrioventricular valve re-
gurgitation were in the CPB group at the time of Fontan
completion. We had primary and staged Fontan completions
in both groups (15 in the no-CPB group and 33 in the CPB
group were staged, Table 2).Immediate Postoperative Results
The mean duration of mechanical ventilation in the no-
CPB group was 25  78 hours, and it was 23  30 hours
in the CPB group (P ¼ .84, Table 3). Because the median
of mechanical ventilation time in our samples was 12 hours,
the patients were analyzed in 2 categories of mechanical
ventilation time: less than or equal to and greater than 12
hours. There was no significant difference in the mechanical
ventilation duration between the no-CPB and CPB groups.
Eighteen patients in both groups had mechanical ventilation
times of greater than 12 hours (P ¼ .38).
The median, mean, and standard deviation of CPB time in
the CPB group was 120, 124, and 42.6 minutes, respectively.
CPB time of greater than 120 minutes caused a meaningful
increase in the mean mechanical ventilation time (35  9.6
vs 13 2.1 hours, P¼ .026) and also increased the incidence
of mechanical ventilation time of greater than 12 hours (12The Journal of Thoracic and Carvs 6 patients, P¼ .04). Bypass time of greater than 120 min-
utes did not influence any other postoperative variable.
There were no meaningful differences between the
no-CPB and CPB groups in the incidence of arrhythmia,
hemodynamic instability, or early mortality.
Twenty-two patients experienced hemodynamic instabil-
ity in this setting: 12 in the no-CPB group and 10 in the CPB
group (P ¼ .91). One early death caused by bleeding from
a tracheostomy occurred in the no-CPB group, and 3 deaths
caused by bleeding, arrhythmia, and intractable low cardiac
output occurred in the CPB group. The remaining 18
patients were successfully treated with inotropic and after-
load-reducing medications. However, 2 patients had tran-
sient left leg paresis, and 1 patient had myocardial
infarction without hemodynamic consequences in the no-
CPB group. The in-hospital mortality rate was 6%, with
a 95% confidence interval of 0.00 to 0.13 for the CPB group
and 1.9%with a 95% confidence interval of 0.00 to 0.05 for
the no-CPB group.
Early in our study, there were 2 patients in whom the con-
duit was initially not fenestrated because of a low TPG (<6–
8 mm Hg), but later in the postoperative period, we had to
take them back to the operating room because of prolonged
and recurrent pleural effusion. Fenestration of the extracar-
diac conduit stopped the pleural effusion in these patients.
There were no meaningful differences between the no-
CPB and CPB groups in either chest tube drainage time
(63  54 vs 72  50 hours, P ¼ .53) or incidence of persis-
tent plural effusion (7/54 vs 6/48, P ¼ .36). Moreover, the
chest tube drainage time was not different in the primary
and staged patients either (63  53 vs 73  52 hours, P ¼
.43). However, there was a trend toward an increased risk
for occurrence of persistent plural effusion in the primary
group (10/54 [18.5%]) compared with that seen in the
staged group (3/48 [6.2%], P ¼ .064).
A 20-year-old patient in the no-CPB group showed signs
and symptoms of postoperative pancreatitis caused by the
high IVC pressure in the off-pump technique. Serum amy-
lase and liver enzyme levels were normalized in the next
days, and the patient remained symptom free in the
follow-up period.
A total of 92 patients were followed. At a mean of 27
months (range, 1–85 months), 89% of patients completed
follow-up. All were in New York Heart Association class
I, except 1 patient who was scheduled for Fontan takedown
3 years after FECTCPC (primary Fontan on CPB) because
of high PVR and recurrent pleural effusion. One patient
has gone through an uncomplicated delivery 7 years after
FECTCPC (primary Fontan operation without CPB). No pa-
tients required late closure of the fenestration either surgi-
cally or with device occluders. Moreover, we did not
notice any increasing incidence of arrhythmia in early or
midterm follow-up. There was no mortality 6 months after
surgical intervention, and since January 2006, we had nodiovascular Surgery c Volume 139, Number 5 1185
TABLE 1. Preoperative and perioperative variables in groups with and without CPB
Phase of study Variable No-CPB group (n ¼ 54) CPB group (n ¼ 48) P value
Preoperative Age (mo) 121  77 113  66 .54
Weight (kg) 28.5  17.1 28.6  16.0 .97
PVR (WU/m2) 2.3  1.87 1.8  2.33 .49
SVC pressure (mm Hg) 8.0  4.1 9.9  4.6 .10
IVC pressure (mm Hg) 7.4  4.9 6.6  3.4 .44
PA pressure (mm Hg) 10.7  4.2 10.7  4.0 .98
Oxygen saturation 0.77  0.10 0.77  0.07 .2
Hemoglobin (g/dL) 17.6  2.4 16.2  2.1 .01
Tricuspid atresia 30 (56%) 15 (31%) .01
Ventricular morphology .1
Right 7 (13%) 14 (29%)
Left 40 (74%) 30 (63%)
Undetermined 7 (13%) 4 (8%)
Perioperative SVC pressure (mm Hg)* 14.0  4.7 13.6  3.7 .66
IVC pressure (mm Hg)* 13.9  3.9 13.5  3.5 .61
PA pressure (mm Hg)* 13.1  4.0 12.1  3.2 .28
CPB, Cardiopulmonary bypass; PVR, pulmonary vascular resistance; SVC, superior vena cava; IVC, inferior vena cava; PA, pulmonary artery. *After fenestration.
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Dearly or late mortalities in the 33 patients undergoing opera-
tions during a period of 3 years. Six late deaths, 4 (7.5%) in
the no-CPB group and 2 (4.4%) in the CPB group, occurred
mainly as a result of the late referral of patients living in rural
areas for drainage of pleural or pericardial effusion. The only
variable related to late death was persistent pleural effusion
(P< .0001). Overall mortality was 10 (9.8%), 5 in each
group (P ¼ .64). Neither the overall mortality nor the early
mortality was influenced by using or avoiding CPB.DISCUSSION
Current dissatisfaction with the early and long-term mor-
bidity rates of children with single-ventricle pathology callsTABLE 2. Previous and concomitant procedures with cavopulmonary







Pulmonary artery band 0 10 (21%)
Interatrial septectomy 4 (7%) 7 (15%)
Shunt 35 (65%) 27 (56%)
Bidirectional Glenn procedure 15 (28%) 33 (69%)





Atrioventricular valve repair 0 5 (10%)





Primary 39 (72%) 15 (31%)
Staged 15 (28%) 33 (69%)
CPB, Cardiopulmonary bypass; VSD, ventricular septal defect; ASD, atrial septal de-
fect; FECTCPC, fenestrated extracardiac total cavopulmonary connection.
1186 The Journal of Thoracic and Cardiovascular Surfor technical modifications in the surgical management of
the disease. Although much has been achieved through bet-
ter selection and technical modification, concerns about the
morbidity and mortality rates of the procedure still remain.
Many factors influence the early and late outcomes of pa-
tients undergoing the Fontan operation, and it is often diffi-
cult to assess the effect of each single modification on
specific morbidity factors.2-5
Avoiding CPB during the Fontan operation has been prac-
ticed as an advantageous technical modification.6-11,14
Adverse effects of CPB have been studied.15,16 Some studies
specifically showed its effects on proinflammatory and vaso-
active substances that canpotentially jeopardize the completed
Fontan circulation and delay recovery.16 Tissuemanipulation,
heparin treatment, and circulation of the blood through the
cannula are the possible causes for the release of inflammatory
and vasoactive substances that should be further investigated.
However, it is important that all of them also occur through the
temporary decompression when CPB is avoided.
Our patient groups (CPB and no-CPB) were similar in
several technical aspects, including having extracardiac con-
duits and fenestrations. However, differentiating character-
istics do exist between the 2 groups. For instance, the
factors that put the patients in the CPB group, such as the
need for an intracardiac procedure, would add additional
preoperative and perioperative risk factors to this group.
Nevertheless, we found that these factors necessitating
CPB did not adversely affect the patients’ outcomes, includ-
ing mechanical ventilation, arrhythmias, hemodynamic in-
stability, and pleural effusion. However, prolonged CPB
time of greater than 120 minutes increased the duration of
mechanical ventilation.
We were also able to exclude the effect of other Fontan
modifications on the selected outcome variables in our co-
hort. In addition, patients included in this study underwentgery c May 2010










25  78 23  30 .83
Chest tube duration (h) 63  54 72  50 .53
Persistent pleural effusion 7 (13%) 6 (13%) .36
Arrhythmia 8 (15%) 12 (25%) .21
Hemodynamic instability 10 (21%) 12 (22%) .91
Early mortality 1 (1.8%) 3 (6.2%) .52
Late mortality 4 (7.5%) 2 (4.4%) .50
CPB, Cardiopulmonary bypass.
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Dsurgical intervention over a relatively short time interval (8
years). This provided more uniformity in the preoperative
selection criteria and postoperative care.
Prolonged pleural effusion remains one of the main unre-
solved complications in the early postoperative period. This
complication has been reported in up to 37% in one report,
when a higher TPG (>12 mmHg) was the basis for fenestra-
tion.17 Excessive pleural drainage as a predictor of poor out-
come depends on multiple factors, and each contributing
pathophysiology that gives rise to the pleural effusion might
in turn be influenced by other specific modifications.
Because there was a trend toward an increased risk for oc-
currence of persistent plural effusion in the primary group
(10 vs 3 patients in the staged group, P ¼ .064), we looked
at it in a different way out of our definition of pleural effu-
sion. We added the patients requiring only one pleural tap
after drain removal to the group with recurrent pleural effu-
sion. Then the difference between the primary Fontan group
and the staged group becomes significant (35% in the pri-
mary Fontan group vs 10% in the staged Fontan group,
P¼ .003). Because this fact could influence our comparison
between the CPB and no-CPB groups, we performed a mul-
tivariable analysis to assess the effect of CPB and staging si-
multaneously. When CPB was used, the incidence of
persistent pleural effusion was similar in the primary or
staged group (3 patients in each group, P ¼ .3), but if
CPB was avoided, the incidence of persistent pleural effu-
sion increased in the primary group (7 patients vs no patients
in the staged group, P ¼ .07). Moreover, staging had no
influence on our results except for the pleural effusion.
Although the lower preoperative oxygen saturation in pa-
tients without a previous bidirectional Glenn procedure (the
primary FECTCPC group) might be a reason for the in-
creased incidence of pleural effusion in this group, it could
not be addressed statistically. Moreover, the increased inci-
dence of persistent pleural effusion after avoiding CPB is
difficult to interpret. The effect of other possible factors
playing a role in persistent plural effusion, such as TA or
non-TA and PVR of greater than 2 Woods units, were not
significant with multivariate analysis, probably because of
the dispersion of the cases.The Journal of Thoracic and CarMuch has been said about the advantages of staging the
Fontan operation. However, there are several disadvantages
as well, especially when the second stage involves perform-
ing an extracardiac conduit from the IVC to the PA without
using CPB. The adhesions make the operation longer and
more tedious. This might be a reason for shifting the staged
patients to CPB in the hands of some surgeons. In older pa-
tients, as in our cohort, the interim morbidity caused by the
desaturation and ventricular volume overload and also the
interim mortality are the other disadvantages of staging total
cavopulmonary connection. It has been reported that staging
would increase the sinoatrial node dysfunction and would
also decrease PA sizes if the forward flow from the ventricle
was not maintained.18,19
Based on previous studies, fenestration decreased the risk
of early postoperative morbidity, such as low cardiac output
and pleural effusion.20,21 Because we fenestrated extracar-
diac conduits in all cases, we were not able to compare
the influence of this modification on the postoperative mor-
bidity between the 2 groups. Our patients had no arterial em-
bolization in both the early and midterm postoperative
periods that could be due to lifelong anticoagulation in all
cases.
A transected main PA leaves a potential space for emboli
formation. Oversewing the cardiac end of the main PA with-
out CPB might create a thrombogenic space between the
pulmonary valves and the suture line at the transected por-
tion of the main PA. Another possible immediate disadvan-
tage of avoiding CPB while performing FECTCPC is the
subsequent high IVC pressure in older patients. This compli-
cation might be avoided through the use of either the acces-
sory decompression cannula routed from the groin toward
the atrium or by side biting the lateral edge of the IVC–atrial
junction to allow blood flow from the IVC to the atrium
during superior conduit anastomosis.
Study Limitations
The older age of the patient population (mean  standard
deviation, 117  72 months) and the lack of a high-risk
group with hypoplastic left heart make this study and its
results not comparable with other studies.22 Moreover, the
unavailability of extracorporeal membrane oxygenation
and a ventricular assist device in our surgical unit are the
other limitations that could influence the overall mortality.
CONCLUSION
Avoiding CPB in patients with FECTCPC was shown to
be feasible and safe but had no direct effect on the patients’
early outcomes. Although this modification seems attractive,
today we have less interest in performing Fontan palliation
without CPB. Further studies involving a larger group of pa-
tients are required to confirm that avoidance of CPB will af-
fect the pleural effusion in the primary Fontan operation or
will decrease the effect of risk factors, such as higherdiovascular Surgery c Volume 139, Number 5 1187
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DPVR. More studies on the proinflammatory and vasoactive
substances might be helpful to show the possible benefit
of avoiding CPB in Fontan palliation.References
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